IMMUNOGENICITY

Clinical trials for IMMUNOGENICITY explained in plain language.

Never miss a new study

Get alerted when new IMMUNOGENICITY trials appear

Sign up with your email to follow new studies for IMMUNOGENICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New eye injection PRO-169 under safety review for Diabetes-Related vision loss

Symptom relief Not yet recruiting

This early-stage study tests whether PRO-169, an eye injection, is safe for people with diabetic macular edema, a condition that causes vision loss in diabetes. The main goal is to see if the body produces antibodies against the drug. About 60 adults with diabetes will take part.

Matched conditions: IMMUNOGENICITY

Phase: PHASE1 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Symptom relief

Last updated Apr 29, 2026 15:02 UTC

IMMUNOGENICITY

Get alerted when new IMMUNOGENICITY trials appear

New eye injection PRO-169 under safety review for Diabetes-Related vision loss